Insider Trading25 Sept 2026, 02:36 pm
GSK Pharma Closes Trading Window for Q2/H1 FY27 Results
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has announced a trading window closure for its shares. This restriction on buying or selling company shares will be in effect from Thursday, October 1, 2026, until 48 hours after the declaration of the Un-audited Financial Results for the second quarter and half year ended September 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing potential insider trading.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is until 48 hours post Q2/H1 FY27 results announcement.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting date for results declaration to be announced soon.
Price Impact
More from GLAXO